Skip to Main Content

Author Details

Elias T Zambidis
Institute for Cell Engineering, The Johns Hopkins University School of Medicine
1996
59
31
Prashant Mali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38086850Harnessing bioengineered myeloid progenitors for precision immunotherapies.NPJ Regen Med2023
34870835Generation of Pericytic-Vascular Progenitors from Tankyrase/PARP-Inhibitor-Regulated Naïve (TIRN) Human Pluripotent Stem Cells.Methods Mol Biol2022
36683654Rosai-Dorfman Disease Presenting as Massive Mediastinal Lymphadenopathy in an Elderly Man.Ann Intern Med Clin Cases2022
35879609Why it is important to study human-monkey embryonic chimeras in a dish.Nat Methods2022
33159275Reduced Intensity Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric Inherited Immune Deficiencies and Bone Marrow Failure Syndromes.J Clin Immunol2021
33656802Elevated glucosylsphingosine in Gaucher disease induced pluripotent stem cell neurons deregulates lysosomal compartment through mammalian target of rapamycin complex 1.Stem Cells Transl Med2021
34001907Running the full human developmental clock in interspecies chimeras using alternative human stem cells with expanded embryonic potential.NPJ Regen Med2021
32139672Vascular progenitors generated from tankyrase inhibitor-regulated naïve diabetic human iPSC potentiate efficient revascularization of ischemic retina.Nat Commun2020
32813874Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults.Blood Adv2020
32151493Pleiotropic roles of tankyrase/PARP proteins in the establishment and maintenance of human naïve pluripotency.Exp Cell Res2020
29514838Infant with a skin lesion and respiratory distress.BMJ Case Rep2018
29939183Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency.J Vis Exp2018
27888014Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies.Biol Blood Marrow Transplant2017
29198828Altered Differentiation Potential of Gaucher's Disease iPSC Neuronal Progenitors due to Wnt/β-Catenin Downregulation.Stem Cell Reports2017
28537488Capturing Human Naïve Pluripotency in the Embryo and in the Dish.Stem Cells Dev2017
28807769Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.Biol Blood Marrow Transplant2017
26729331Variability of Action Potentials Within and Among Cardiac Cell Clusters Derived from Human Embryonic Stem Cells.Sci Rep2016
26343947Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen-Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies.Biol Blood Marrow Transplant2016
27660325Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality.Development2016
27688775High-Fidelity Reprogrammed Human IPSCs Have a High Efficacy of DNA Repair and Resemble hESCs in Their MYC Transcriptional Signature.Stem Cells Int2016
27293150Integrated Genomic Analysis of Diverse Induced Pluripotent Stem Cells from the Progenitor Cell Biology Consortium.Stem Cell Reports2016
27159521Enrichment of Scleroderma Vascular Disease-Associated Autoantigens in Endothelial Lineage Cells.Arthritis Rheumatol2016
26860634Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant Disorders.Biol Blood Marrow Transplant2016
26062980Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis.Stem Cells Transl Med2015
26154167Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.Stem Cells Dev2015
24163065Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature.Circulation2014
25461449Cancer-like epigenetic derangements of human pluripotent stem cells and their impact on applications in regeneration and repair.Curr Opin Genet Dev2014
25027006Induced pluripotent stem cells from familial Alzheimer's disease patients differentiate into mature neurons with amyloidogenic properties.Stem Cells Dev2014
25148658Automated grouping of action potentials of human embryonic stem cell-derived cardiomyocytes.IEEE Trans Biomed Eng2014
24801745Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development.Stem Cells2014
24915161Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs.Nat Commun2014
24660130Dynamic Interactions Between Cancer Stem Cells And Their Stromal Partners.Curr Pathobiol Rep2014
22736485Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells.Cytometry A2013
23747841Mesenchymal stem cell secretome and regenerative therapy after cancer.Biochimie2013
23390563Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity.Am J Transl Res2013
23546754Highly efficient directed differentiation of human induced pluripotent stem cells into cardiomyocytes.Methods Mol Biol2013
23104383Pivots of pluripotency: the roles of non-coding RNA in regulating embryonic and induced pluripotent stem cells.Biochim Biophys Acta2013
22905176Growth factor-activated stem cell circuits and stromal signals cooperatively accelerate non-integrated iPSC reprogramming of human myeloid progenitors.PLoS One2012
23166588HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks.PLoS One2012
22971665Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility.Prog Biophys Mol Biol2012
22958937Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells.Prog Biophys Mol Biol2012
23071332Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease.Proc Natl Acad Sci U S A2012
22713758Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model.J Mol Cell Cardiol2012
21494607A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability.PLoS One2011
20563986Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells.Int J Dev Biol2010
20841480Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells.Cancer Res2010
20541472Erythropoietic differentiation of a human embryonic stem cell line harbouring the sickle cell anaemia mutation.Reprod Biomed Online2010
18954935Human embryonic stem cell-derived hematoendothelial progenitors engraft chicken embryos.Exp Hematol2009
19326416False-photosensitivity and transient hemiparesis following high-dose intravenous and intrathecal methotrexate for treatment of acute lymphoblastic leukemia.Pediatr Blood Cancer2009
19483149A role for the renin-angiotensin system in hematopoiesis.Haematologica2009
  • 1 - 50 of 59

Recommended Authors

Jizhong Zou
and Blood Institute, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 9
Xiaosong Huang
Guangzhou University
Career Start Year 2007
Number of shared co-authors 6
Vittorio Sebastiano
Stanford University
Career Start Year 2004
Number of shared co-authors 1
Nuria Montserrat
Catalan Institution for Research and Advanced Studies (ICREA)
Career Start Year 2004
Number of shared co-authors 2
Guokai Chen
University of Macau
Career Start Year 2002
Number of shared co-authors 0
In-Hyun Park
Yale School of Medicine
Career Start Year 2002
Number of shared co-authors 4
Zhaohui Ye
Center for Biologics Evaluation and Research
Career Start Year 2002
Number of shared co-authors 11
Sergei Doulatov
University of Washington
Career Start Year 2002
Number of shared co-authors 0
Guibin Chen
and Blood Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 7
Xiaobing Yu
Heidelberg University
Career Start Year 2000
Number of shared co-authors 12
Thomas P Zwaka
Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 0
Yoon-Young Jang
Daegu Catholic University Medical Center, Catholic University of Daegu
Career Start Year 1999
Number of shared co-authors 10
Yaowalak U-Pratya
Faculty of Medicine Siriraj Hospital, Mahidol University
Career Start Year 1998
Number of shared co-authors 0
Amy J Wagers
Joslin Diabetes Center
Career Start Year 1996
Number of shared co-authors 3
Jeanette Beers
and Blood Institute, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 0
Bin-Kuan Chou
The Institute for Cell Engineering, Johns Hopkins University
Career Start Year 1995
Number of shared co-authors 10
Dmitry A Ovchinnikov
The Florey Institute for Neuroscience and Mental Health, University of Melbourne
Career Start Year 1994
Number of shared co-authors 2
Yukio Nakamura
RIKEN BioResource Research Center
Career Start Year 1992
Number of shared co-authors 0
Daisuke Sugiyama
Translational Research Center, Hiroshima University
Career Start Year 1992
Number of shared co-authors 2
Carl Anthony Blau
Center for Cancer Innovation, University of Washington
Career Start Year 1991
Number of shared co-authors 2
Mahendra S Rao
Institute of Stem Cells and Regenerative Medicine (inStem)
Career Start Year 1990
Number of shared co-authors 5
William L Stanford
Ottawa Hospital Research Institute
Career Start Year 1989
Number of shared co-authors 1
Dirk Strunk
Cell Therapy Institute, Paracelsus Medical University (PMU)
Career Start Year 1987
Number of shared co-authors 0
Ernst J Wolvetang
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Career Start Year 1987
Number of shared co-authors 2
Lesley M Forrester
Institute of Regeneration and Repair, The University of Edinburgh
Career Start Year 1984
Number of shared co-authors 0
George Q Daley
Boston Children's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 7
Hiromitsu Nakauchi
Advanced Research Institute, Tokyo Medical and Dental University
Career Start Year 1981
Number of shared co-authors 5
Christine L Mummery
Leiden University Medical Center
Career Start Year 1981
Number of shared co-authors 3
Anne M Dickinson
Translational and Clinical Research Institute, Newcastle University
Career Start Year 1981
Number of shared co-authors 0
John E Dick
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1980
Number of shared co-authors 1

Collaborators

Richard J Jones
Sidney Kimmel Cancer Center, Johns Hopkins University
Co-authored papers 5
Leslie Cope
Johns Hopkins University School of Medicine
Co-authored papers 4
David W Scott
University of British Columbia
Co-authored papers 4
David M Loeb
Children's Hospital at Montefiore.
Co-authored papers 4
Feyruz V Rassool
University of Maryland Greenebaum Comprehensive Cancer Center
Co-authored papers 3
Stephen B Baylin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Co-authored papers 3
John P Cooke
Co-authored papers 2
Alejandro De Los Angeles
Massachusetts Institute of Technology
Co-authored papers 2
Michael J Considine
Johns Hopkins University School of Medicine
Co-authored papers 2
Cyndi F Liu
The Johns Hopkins University School of Medicine
Co-authored papers 2
Wayne Yu
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Co-authored papers 2
Curt I Civin
Center for Stem Cell Biology & Regenerative Medicine and.
Co-authored papers 1
Christian F Meyer
Johns Hopkins University School of Medicine
Co-authored papers 1
Antony Rosen
Johns Hopkins University
Co-authored papers 1
Linda M S Resar
Johns Hopkins University School of Medicine
Co-authored papers 1
William Matsui
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Co-authored papers 1
Adam A Margolin
Icahn School of Medicine
Co-authored papers 1
Mitinori Saitou
Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University
Co-authored papers 1
Prashant Mali (CM4AI)
University of California San Diego
Co-authored papers 1
David M Berman
Queen's University
Co-authored papers 1
Linzhao Cheng
Johns Hopkins University School of Medicine
Co-authored papers 1
Liang Liang
Tangdu Hospital, Fourth Military Medical University
Co-authored papers 1
Robert A Brodsky
Sidney Kimmel Cancer Center, Johns Hopkins University
Co-authored papers 1
Yuliang Wang
Nanjing Medical University
Co-authored papers 1
Tong Li
Co-authored papers 1
Kenneth Daily
Co-authored papers 1
Michael A Koldobskiy
Co-authored papers 1
Nam Pho
Co-authored papers 1
Shannan J Ho Sui
Harvard T.H. Chan School of Public Health
Co-authored papers 1
John D Gearhart
Johns Hopkins Hospital
Co-authored papers 1
Release 1.2